Panacea Innovation Ltd - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Filing Manager
Panacea Innovation Ltd
Reporting Manager
Panacea Venture Healthcare Fund II, L.P.
Security
Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol
AMLX
Shares outstanding
84.6M shares
Disclosed Ownership
2.2M shares
Ownership
2.6%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:30 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 2.6% 2.2M 0 2.2M By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang James Huang, Founding Managing Partner
Panacea Venture Healthcare Fund II GP Company, Ltd. 2.6% 2.2M 0 2.2M By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 2.6% 2.2M 0 2.2M /s/ James Huang James Huang, Founding Managing Partner
James Huang 2.6% 2.2M 0 2.2M /s/ James Huang James Huang